These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21385167)

  • 1. Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring.
    Nie H; Cheng J; Small DS
    Biometrics; 2011 Dec; 67(4):1397-405. PubMed ID: 21385167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
    Odondi L; McNamee R
    Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bias analysis of the instrumental variable estimator as an estimator of the average causal effect.
    Chiba Y
    Contemp Clin Trials; 2010 Jan; 31(1):12-7. PubMed ID: 19879376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making sense of clinical trial data: is inverse probability of censoring weighted analysis the answer to crossover bias?
    Rimawi M; Hilsenbeck SG
    J Clin Oncol; 2012 Feb; 30(4):453-8. PubMed ID: 22215751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administrative and artificial censoring in censored regression models.
    Joffe MM
    Stat Med; 2001 Aug; 20(15):2287-304. PubMed ID: 11468764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric inference on median residual life function.
    Jeong JH; Jung SH; Costantino JP
    Biometrics; 2008 Mar; 64(1):157-63. PubMed ID: 17501936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
    Julian-Reynier C; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; Maraninchi D;
    J Clin Oncol; 2007 Jul; 25(21):3038-44. PubMed ID: 17536083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the risk difference under a noncompliance randomized clinical trial with missing outcomes.
    Lui KJ
    J Biopharm Stat; 2008; 18(2):273-92. PubMed ID: 18327721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principal stratification with predictors of compliance for randomized trials with 2 active treatments.
    Roy J; Hogan JW; Marcus BH
    Biostatistics; 2008 Apr; 9(2):277-89. PubMed ID: 17681993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential monitoring of randomization tests: stratified randomization.
    Zhang Y; Rosenberger WF; Smythe RT
    Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
    Taylor L; Zhou XH
    Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for sequential analysis of survival data with nonproportional hazards.
    Sooriyarachchi MR; Whitehead J
    Biometrics; 1998 Sep; 54(3):1072-84. PubMed ID: 9750253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Levin BJ; Thompson G; Mitsumoto LH; Kaufmann P
    Neurology; 2006 Jun; 66(11):1786-7; author reply 1786-7. PubMed ID: 16769973
    [No Abstract]   [Full Text] [Related]  

  • 17. Analyses of cumulative incidence functions via non-parametric multiple imputation.
    Ruan PK; Gray RJ
    Stat Med; 2008 Nov; 27(27):5709-24. PubMed ID: 18712779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discussions.
    Have TT
    Biometrics; 2007 Sep; 63(3):654-5. PubMed ID: 17824997
    [No Abstract]   [Full Text] [Related]  

  • 19. Noncompliance in cancer screening trials.
    Gareen IF
    Clin Trials; 2007; 4(4):341-9. PubMed ID: 17848495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population.
    Hadley J; Polsky D; Mandelblatt JS; Mitchell JM; Weeks JC; Wang Q; Hwang YT;
    Health Econ; 2003 Mar; 12(3):171-86. PubMed ID: 12605463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.